Analysis of the Relationship Between the Quality of Small Biopsy Specimens of Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene
Background and objective Epidermal growth factor receptor (EGFR) is the gene with the highest mutation rate in non-small cell lung cancer (NSCLC) patients, and the accurate evaluation of its mutational status can facilitate patients receiving targeted drug therapy and thereby prolong patients’ survi...
Main Authors: | Yuqin LI, Yingying GU, Juhong JIANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-05-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.16 |
Similar Items
-
Investigation on the Possibility of EGFR Mutation Testing on DNA Extracted from
Fixation Liquid of Lung Cancer Biopsy
by: Xuanzhi LIAO, et al.
Published: (2019-07-01) -
Comparison of EGFR and KRAS Status between Primary Non-small Cell Lung Cancer and Corresponding Metastases: A Systematic Review and meta-analysis
by: Chengbo HAN, et al.
Published: (2010-09-01) -
EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01) -
Real-World Analysis of the <i>EGFR</i> Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer
by: Hyunwoo Lee, et al.
Published: (2021-09-01) -
A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer
with Uncommon EGFR Mutations
by: Wenxing DU, et al.
Published: (2019-09-01)